Correction: Hyperferritinemia & hyperuricemia may be associated with liver function abnormality in obese adolescents (PLoS ONE (2012) 7:10 (e48645) DOI: 10.1371/journal.pone.0048645);Hyperferritinemia and Hyperuricemia May Be Associated with Liver Function Abnormality in Obese Adolescents

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Chen, Solomon Chih Cheng ^a,b   Huang, Ya Fang ^c   Wang, Jung Der ^d  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868267226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173849     Document Type: Erratum

References (43)

1. Chen SC, Yeh JJ, Chang MH, Liao YK, Hsiao LC, et al. (2010) Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents. PLoS ONE 5: e13269.
2. Aigner E, Hinz C, Steiner K, Rossmann B, Pfleger J, et al. (2010) Iron stores, liver transaminase levels and metabolic risk in healthy teenagers. Eur J Clin Invest 40: 155-163.
3. Stevens D, (2000) Iron fortified follow on formula from 9 to 18 months improves iron status but not development or growth. Arch Dis Child 82: 269-270.
4. Britton RS, Leicester KL, Bacon BR, (2002) Iron toxicity and chelation therapy. Int J Hematol 76: 219-228.
5. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761.
6. Albano E, Mottaran E, Occhino G, Reale E, Vidali M, (2005) Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment Pharmacol Ther 22 (Suppl 2) (): 71-73.
7. Sanyal AJ, (2005) Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2: 46-53.
8. Fleming RE, Ponka P, (2012) Iron overload in human disease. N Engl J Med 366: 348-359.
9. Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, et al. (2011) Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int 31: 730-739.
10. Arosio P, Ingrassia R, Cavadini P, (2009) Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589-599.
11. Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, et al. (2012) Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 55: 77-85.
12. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
13. Kang YH, Min HG, Kim IJ, Kim YK, Son SM, (2008) Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults. Endocr J 55: 1093-1102.
14. Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G, (1988) Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 34: 1622-1625.
15. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, et al. (2003) Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 325: 53-62.
16. (2012) Centers for Disease Control and Prevention. Hemochromatosis (iron storage disease): Diagnosis. Centers for Disease Control and Prevention.
17. (2012) Iron Disorders Institute. Iron tests.
18. Teehan GS, Ruthazer R, Balakrishnan VS, Snydman D, Jaber BL, (2004) Iron storage indices and risk of bacterial infections in hemodialysis patients. Hemodial Int 8: 226-232.
19. Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, et al. (2010) Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. J Vasc Surg 51: 1498-1503.
20. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE, (2005) Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115: e561-565.
21. Ruhl CE, Everhart JE, (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124: 71-79.
22. Le Page L, Leflon P, Mahevas M, Duhaut P, Smail A, et al. (2005) [Aetiological spectrum of hyperferritinemia]. Rev Med Interne 26: 368-373.
23. Torti FM, Torti SV, (2002) Regulation of ferritin genes and protein. Blood 99: 3505-3516.
24. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM, (2009) Ferritin for the clinician. Blood Rev 23: 95-104.
25. Cheng HL, Bryant C, Cook R, O'Connor H, Rooney K, et al. (2012) The relationship between obesity and hypoferraemia in adults: a systematic review. Obes Rev 13: 150-161.
26. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA, (2005) Uric acid and oxidative stress. Curr Pharm Des 11: 4145-4151.
27. Facchini FS, Hua NW, Stoohs RA, (2002) Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 122: 931-939.
28. Ghio AJ, Ford ES, Kennedy TP, Hoidal JR, (2005) The association between serum ferritin and uric acid in humans. Free Radic Res 39: 337-342.
29. Johnson S, (1999) Effect of gradual accumulation of iron, molybdenum and sulfur, slow depletion of zinc and copper, ethanol or fructose ingestion and phlebotomy in gout. Med Hypotheses 53: 407-412.
30. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, et al. (2002) Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 25: 2249-2255.
31. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, et al. (2007) Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 102: 1251-1258.
32. Valenti L, Fracanzani AL, Fargion S (2003) Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance. Gastroenterology 124: 866; author reply 866-867.
33. Carlo C, Daniela P, Giancarlo C, (2003) Iron depletion and response to interferon in chronic hepatitis C. Hepatogastroenterology. 50: 1467-1471.
34. Petta S, Camma C, Di Marco V, Alessi N, Cabibi D, et al. (2008) Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 103: 1136-1144.
35. Ghaziani T, Alavian SM, Zali MR, Shahraz S, Agah M, et al. (2007) Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection. Hepatol Res 37: 172-178.
36. Kladchareon N, Treeprasertsuk S, Mahachai V, Wilairatana P, Kullavanijaya P, (2004) The prevalence of nonalcoholic steatohepatitis in Thai patients with non-HBV, non-HCV chronic hepatitis. J Med Assoc Thai 87 (Suppl 2) (): S29-34.
37. Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D, (2006) The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. Liver Int 26: 298-304.
38. Romagnuolo J, Andrews CN, Bain VG, Bonacini M, Cotler SJ, et al. (2005) Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model. Scand J Gastroenterol 40: 1365-1371.
39. Riquelme A, Soza A, Nazal L, Martinez G, Kolbach M, et al. (2004) Histological resolution of steatohepatitis after iron depletion. Dig Dis Sci 49: 1012-1015.
40. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, et al. (1991) Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13: 830-833.
41. Chang MH, Lee CY, Chen DS, (1993) Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection. J Med Virol 40: 322-325.
42. Hsu HC, Lin CK, Tsay SH, Tse E, Ho CH, et al. (1990) Iron overload in Chinese patients with hemoglobin H disease. Am J Hematol 34: 287-290.
43. Mah YH, Kao JH, Liu CJ, Chen CL, Chen PJ, et al. (2005) Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan. Liver Int 25: 214-219.